Trinity Street Asset Management LLP Buys 54,669 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Trinity Street Asset Management LLP raised its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 21.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 303,915 shares of the company's stock after acquiring an additional 54,669 shares during the quarter. Bath & Body Works accounts for about 1.5% of Trinity Street Asset Management LLP's investment portfolio, making the stock its 17th largest holding. Trinity Street Asset Management LLP owned approximately 0.13% of Bath & Body Works worth $13,117,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Bath & Body Works by 0.3% during the third quarter. Vanguard Group Inc. now owns 25,689,543 shares of the company's stock worth $868,307,000 after buying an additional 67,920 shares in the last quarter. BlackRock Inc. grew its position in shares of Bath & Body Works by 1.0% during the first quarter. BlackRock Inc. now owns 17,074,153 shares of the company's stock worth $624,573,000 after buying an additional 174,915 shares in the last quarter. Third Point LLC grew its position in shares of Bath & Body Works by 0.7% during the second quarter. Third Point LLC now owns 13,850,000 shares of the company's stock worth $519,375,000 after buying an additional 98,900 shares in the last quarter. State Street Corp grew its position in shares of Bath & Body Works by 0.6% during the third quarter. State Street Corp now owns 10,038,767 shares of the company's stock worth $327,264,000 after buying an additional 58,201 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Bath & Body Works by 8.2% during the second quarter. Price T Rowe Associates Inc. MD now owns 6,364,253 shares of the company's stock worth $171,326,000 after buying an additional 484,674 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Analyst Ratings Changes

BBWI has been the subject of a number of research reports. Robert W. Baird lifted their price objective on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an "outperform" rating in a report on Friday, March 1st. Barclays downgraded shares of Bath & Body Works from an "overweight" rating to an "equal weight" rating and lifted their price objective for the stock from $37.00 to $45.00 in a report on Thursday, January 4th. Wells Fargo & Company lifted their price objective on shares of Bath & Body Works from $40.00 to $42.00 and gave the stock an "equal weight" rating in a report on Friday, March 1st. BMO Capital Markets lifted their price objective on shares of Bath & Body Works from $48.00 to $50.00 and gave the stock an "outperform" rating in a report on Friday, March 1st. Finally, TD Cowen lifted their price objective on shares of Bath & Body Works from $35.00 to $55.00 and gave the stock an "outperform" rating in a report on Friday, March 1st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, Bath & Body Works has a consensus rating of "Hold" and a consensus target price of $45.80.

Insiders Place Their Bets

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the business's stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total value of $209,493.65. Following the sale, the insider now directly owns 45,992 shares in the company, valued at $2,248,548.88. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.19% of the stock is owned by company insiders.

Bath & Body Works Price Performance

Shares of NYSE BBWI traded up $0.32 during midday trading on Friday, reaching $45.49. 5,381,520 shares of the company traded hands, compared to its average volume of 2,202,679. Bath & Body Works, Inc. has a 52 week low of $27.30 and a 52 week high of $50.34. The stock has a 50-day moving average price of $45.89 and a 200 day moving average price of $39.35. The company has a market cap of $10.23 billion, a price-to-earnings ratio of 11.82, a PEG ratio of 1.52 and a beta of 1.86.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The firm had revenue of $2.91 billion for the quarter, compared to analysts' expectations of $2.84 billion. During the same period in the previous year, the business earned $1.86 earnings per share. Bath & Body Works's revenue for the quarter was up .8% compared to the same quarter last year. As a group, analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 1.76%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works's dividend payout ratio (DPR) is presently 20.78%.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.